Molecular characterization and localization of the human MAFG gene.

The human MAFG gene encodes a basic-leucine zipper (bZIP) protein that belongs to a family of transcription factors related to the v-maf oncogene. The ubiquitously expressed MAFG protein dimerizes with blood cell-specific bZIP factor p45 NF-E2, indicating that it may play a role in regulating hematopoietic gene expression. We have characterized the human MAFG gene and shown that it consists of at least three exons, which are separated by small introns. The first exon is not translated. The genomic structure of the MAFG locus is highly conserved between human and chicken. We have mapped the MAFG gene to human chromosome region 17q25 by fluorescence in situ hybridization. Several putative human disease loci have been mapped to this telomeric portion of chromosome 17.

[1]  N. Andrews,et al.  Human MafG is a functional partner for p45 NF-E2 in activating globin gene expression. , 1997, Blood.

[2]  T. Glover,et al.  FISH localization of the soluble thymidine kinase gene (TK1) to human 17q25, a region of chromosomal loss in sporadic breast tumors. , 1996, Cytogenetics and cell genetics.

[3]  S. Orkin,et al.  Regulation of globin gene expression in erythroid cells. , 1995, European journal of biochemistry.

[4]  K. Kataoka,et al.  Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor , 1995, Molecular and cellular biology.

[5]  N. Dracopoli,et al.  Current protocols in human genetics , 1994 .

[6]  S. Orkin,et al.  Transcriptional control of erythropoiesis. , 1994, Current opinion in hematology.

[7]  Ken Itoh,et al.  Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins , 1994, Nature.

[8]  R. Zeillinger,et al.  Patterns of allele losses suggest the existence of five distinct regions of loh on chromosome 17 in breast cancer , 1994, International journal of cancer.

[9]  Jane A. Langdale,et al.  In situ Hybridization , 1994 .

[10]  S. Orkin,et al.  The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  V. Desmet,et al.  Alveolar soft‐part sarcoma: evidence for its myogenic origin and for the involvement of 17q25 , 1993, Histopathology.

[12]  S. Orkin,et al.  Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner , 1993, Molecular and cellular biology.

[13]  J. Rowley,et al.  Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridization. , 1993, Blood.

[14]  Y. Nakamura,et al.  Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. , 1993, Cancer research.

[15]  Paul Tempst,et al.  Erythroid transcription factor NF-E2 is a haematopoietic-specific basic–leucine zipper protein , 1993, Nature.

[16]  P. Devilee,et al.  Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions. , 1993, Oncogene.

[17]  Mark L. Greenberg,et al.  Molecular genetic, cytogenetic, and immunohistochemical characterization of alveolar soft‐part sarcoma: Implications for cell of origin , 1992, Cancer.

[18]  K. Yamada,et al.  [Complex chromosome aberrations between no. 17 and no. 21 in acute myelo-megakaryocytic leukemia: a case report]. , 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[19]  Marvin B. Shapiro,et al.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.